Council Workgroups

Clinical Trials Network Workgroup


To provide external scientific input and recommendations for current and future research projects of NIDA’s National Drug Abuse Treatment Clinical Trials Network (CTN)


Carlos del Rio, M.D.
Hubert professor and Chair
Hubert Department of Global Health
Rollins School of Public Health
Emory University

Hillary Kunins, M.D.
Assistant Commissioner
NYC Department of Health and Mental Hygiene
Clinical Professor
Albert Einstein College of Medicine

Barbara Cimaglio, BA
Project Director
Access to Medication-Assisted Treatment
Division of Substance Use Prevention and Recovery
Illinois Department of Human Services

Dennis McCarty, Ph.D.
Department of Public Health and Preventive Medicine
Oregon Health & Science University

Division of Therapeutics and Medical Consequences Workgroup


To provide scientific input on the current and future research portfolio for NIDA’s Division of Therapeutics and Medical Consequences.

To provide input on the development of medications and devices to treat SUD and review concepts and recommend emerging pharmacotherapies, behavioral therapies and devices to treat SUD.


Kalpana Merchant, Ph.D.
Chief Scientific Officer
Vincere Biosciences

Lisa Gold, Ph.D.
Retired - Merck

David McKinzie, Ph.D.
Professor of Pharmacology & Toxicology
Indiana University School of Medicine
Stark Neurosciences Research Institute

Chris Schmidt, Ph.D.
Retired - Pfizer